Literature DB >> 16113301

Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Tatiana R de Moura1, Fernanda O Novais, Fabiano Oliveira, Jorge Clarêncio, Almério Noronha, Aldina Barral, Claudia Brodskyn, Camila I de Oliveira.   

Abstract

Leishmania spp. cause a broad spectrum of diseases collectively known as leishmaniasis. Leishmania braziliensis is the main etiological agent of American cutaneous leishmaniasis (ACL) and mucocutaneous leishmaniasis. In the present study, we have developed an experimental model of infection that closely resembles ACL caused by L. braziliensis. In order to do so, BALB/c mice were infected in the ear dermis with 10(5) parasites and distinct aspects of the infection were evaluated. Following inoculation, parasite expansion in the ear dermis was accompanied by the development of an ulcerated dermal lesion which healed spontaneously, as seen by the presence of a scar. Histological analysis of infected ears showed the presence of a mixed inflammatory infiltrate consisting of both mononuclear and polymorphonuclear cells. In draining lymph nodes, parasite replication was detected throughout the infection. In vitro restimulation of draining lymph node cells followed by intracellular staining showed an up-regulation in the production of gamma interferon (IFN-gamma) and in the frequency of IFN-gamma-secreting CD4(+) and CD8(+) T cells. Reverse transcription-PCR of ears and draining lymph node cells showed the expression of CC chemokines. The dermal model of infection with L. braziliensis herein is able to reproduce aspects of the natural infection, such as the presence of an ulcerated lesion, parasite dissemination to lymphoid areas, and the development of a Th1-type immune response. These results indicate that this model shall be useful to address questions related to the concomitant immunity to reinfection and parasite persistence leading to mucocutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113301      PMCID: PMC1231065          DOI: 10.1128/IAI.73.9.5827-5834.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

Authors:  Y Belkaid; S Mendez; R Lira; N Kadambi; G Milon; D Sacks
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 3.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

4.  Analysis of the immune responses of mice to infection with Leishmania braziliensis.

Authors:  G K DeKrey; H C Lima; R G Titus
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors:  Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

6.  New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species.

Authors:  Tiago M Castilho; Jeffrey Jon Shaw; Lucile M Floeter-Winter
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Leishmania (Viannia) braziliensis metacyclic promastigotes purified using Bauhinia purpurea lectin are complement resistant and highly infective for macrophages in vitro and hamsters in vivo.

Authors:  Lucia H Pinto-da-Silva; Marcelle Camurate; Karina A Costa; Sandra M P Oliveira; Narcisa L da Cunha-e-Silva; Elvira M B Saraiva
Journal:  Int J Parasitol       Date:  2002-10       Impact factor: 3.981

8.  Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide.

Authors:  Sandip Bhattacharyya; Sanjukta Ghosh; Biplab Dasgupta; Debashis Mazumder; Syamal Roy; Subrata Majumdar
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

9.  CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response.

Authors:  K Venuprasad; Subhasis Chattopadhyay; Bhaskar Saha
Journal:  Hum Immunol       Date:  2003-01       Impact factor: 2.850

10.  Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.

Authors:  Nathalie Courret; Thierry Lang; Geneviève Milon; Jean Claude Antoine
Journal:  Int J Parasitol       Date:  2003-10       Impact factor: 3.981

View more
  49 in total

1.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

2.  The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.

Authors:  Rajendranath Ramasawmy; Eliane Menezes; Andrea Magalhães; Joyce Oliveira; Léa Castellucci; Roque Almeida; Maria Elisa A Rosa; Luiz Henrique Guimarães; Marcus Lessa; Elza Noronha; Mary E Wilson; Sarra E Jamieson; Jorge Kalil; Jenefer M Blackwell; Edgar M Carvalho; Amélia Ribeiro de Jesus
Journal:  Infect Genet Evol       Date:  2010-04-27       Impact factor: 3.342

3.  Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.

Authors:  Augusto M Carvalho; Juqueline R Cristal; Aline C Muniz; Lucas P Carvalho; Regis Gomes; José C Miranda; Aldina Barral; Edgar M Carvalho; Camila I de Oliveira
Journal:  J Infect Dis       Date:  2015-01-16       Impact factor: 5.226

4.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

5.  Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fabiano Oliveira; Gabriele C Rodrigues; Marcia W Carneiro; Kiyoshi F Fukutani; Fernanda O Novais; José Carlos Miranda; Manoel Barral-Netto; Claudia Brodskyn; Aldina Barral; Camila I de Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

6.  Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi.

Authors:  Luiz Felipe Domingues Passero; Juliano V Sacomori; Thaíse Yumie Tomokane; Carlos Eduardo Pereira Corbett; Fernando Tobias da Silveira; Márcia Dalastra Laurenti
Journal:  Parasitol Res       Date:  2009-09-16       Impact factor: 2.289

7.  Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses.

Authors:  Diego A Vargas-Inchaustegui; Lijun Xin; Lynn Soong
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 8.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

9.  Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations.

Authors:  Raquel P Ribeiro-Romão; Otacílio C Moreira; Elvia Yaneth Osorio; Lea Cysne-Finkelstein; Adriano Gomes-Silva; Joanna G Valverde; Claude Pirmez; Alda Maria Da-Cruz; Eduardo Fonseca Pinto
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

10.  Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.

Authors:  G Salay; M L Dorta; N M Santos; R A Mortara; C Brodskyn; C I Oliveira; C L Barbiéri; M M Rodrigues
Journal:  Clin Vaccine Immunol       Date:  2007-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.